Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C29H48O |
Molecular Weight | 412.6908 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 8 / 8 |
E/Z Centers | 1 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]1(CC[C@@]2([H])[C@]3([H])CC=C4C[C@@H](O)CC[C@]4(C)[C@@]3([H])CC[C@]12C)[C@H](C)CC\C(=C/C)C(C)C
InChI
InChIKey=OSELKOCHBMDKEJ-JUGJNGJRSA-N
InChI=1S/C29H48O/c1-7-21(19(2)3)9-8-20(4)25-12-13-26-24-11-10-22-18-23(30)14-16-28(22,5)27(24)15-17-29(25,26)6/h7,10,19-20,23-27,30H,8-9,11-18H2,1-6H3/b21-7+/t20-,23+,24+,25-,26+,27+,28+,29-/m1/s1
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/2775538 | https://www.ncbi.nlm.nih.gov/pubmed/1186438 | https://www.ncbi.nlm.nih.gov/pubmed/5343809 | https://www.ncbi.nlm.nih.gov/pubmed/10576216 | https://www.ncbi.nlm.nih.gov/pubmed/24684169https://www.ncbi.nlm.nih.gov/pubmed/26455344 | https://www.ncbi.nlm.nih.gov/pubmed/28134973 | https://www.ncbi.nlm.nih.gov/pubmed/28637390 | https://www.ncbi.nlm.nih.gov/pubmed/23116181 | https://www.ncbi.nlm.nih.gov/pubmed/23994501
Sources: https://www.ncbi.nlm.nih.gov/pubmed/2775538 | https://www.ncbi.nlm.nih.gov/pubmed/1186438 | https://www.ncbi.nlm.nih.gov/pubmed/5343809 | https://www.ncbi.nlm.nih.gov/pubmed/10576216 | https://www.ncbi.nlm.nih.gov/pubmed/24684169https://www.ncbi.nlm.nih.gov/pubmed/26455344 | https://www.ncbi.nlm.nih.gov/pubmed/28134973 | https://www.ncbi.nlm.nih.gov/pubmed/28637390 | https://www.ncbi.nlm.nih.gov/pubmed/23116181 | https://www.ncbi.nlm.nih.gov/pubmed/23994501
Fucosterol (24-ethylidene cholesterol) is a sterol that can be isolated from algae, seaweed and diatoms. Fucosterol exhibits various biological therapeutics, including anticancer, antidiabetic, antioxidant, hepatoprotective, antihyperlipidemic, antifungal, antihistaminic, anticholinergic, antiadipogenic, antiphotodamaging, anti-osteoporotic, blood cholesterol reducing, blood vessel thrombosis preventive and butyrylcholinesterase inhibitory activities. Fucosterol showed higher antiplasmodial activity as compared to chloroquine. Fucosterol showed the increase in the anti-oxidant enzymes such as hepatic cytosolic superoxide dismutase (SOD), catalase and glutathione peroxidase (GSH-px) activities in CCl4-intoxicated rats. Fucosterol inhibited adipogenesis of 3T3-L1 preadipocytes through modulation of FoxO signalling pathway. Fucosterol is a dual-LXR agonist. It is displayed moderate inhibitory activity against aldose reductase and PTP1B.
CNS Activity
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL2808 Sources: https://www.ncbi.nlm.nih.gov/pubmed/23116181 |
464.0 nM [EC50] | ||
Target ID: CHEMBL4093 Sources: https://www.ncbi.nlm.nih.gov/pubmed/23116181 |
1391.0 nM [EC50] | ||
Target ID: GO:0034440 Sources: https://www.ncbi.nlm.nih.gov/pubmed/14560919 |
|||
Target ID: CHEMBL1900 Sources: https://www.ncbi.nlm.nih.gov/pubmed/23994501 |
143.0 µM [IC50] | ||
Target ID: CHEMBL335 Sources: https://www.ncbi.nlm.nih.gov/pubmed/23994501 |
77.13 µM [Ki] | ||
Target ID: map04068 Sources: https://www.ncbi.nlm.nih.gov/pubmed/28134973 |
|||
Target ID: CHEMBL1687677 Sources: https://www.ncbi.nlm.nih.gov/pubmed/24684169 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Unknown Approved UseUnknown |
|||
Primary | Unknown Approved UseUnknown |
|||
Primary | Unknown Approved UseUnknown |
|||
Primary | Unknown Approved UseUnknown |
PubMed
Title | Date | PubMed |
---|---|---|
Incorporation of (2-14C, (5r)-5-3H1) mevalonic acid into cholesterol by a rat liver homogenate and into beta-sitosterol and 28-isofucosterol by larix decidua leaves. | 1969 Oct |
|
Incorporation of [2-14C] mevalonic acid into 28-isofucosterol by leaves of Pisum sativum. | 1969 Oct |
|
28-Isofucosterol: major sterol of a marine sponge. | 1975 Jul-Aug |
|
Inhibition of Mycobacterium tuberculosis growth by saringosterol from Lessonia nigrescens. | 2001 Nov |
|
Inhibitory activity on HIV-1 reverse transcriptase and integrase of a carmalol derivative from a brown Alga, Ishige okamurae. | 2006 Aug |
|
Kinetics and molecular docking studies of an anti-diabetic complication inhibitor fucosterol from edible brown algae Eisenia bicyclis and Ecklonia stolonifera. | 2013 Oct 25 |
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
DSLD |
1408 (Number of products:1)
Created by
admin on Sat Dec 16 19:58:10 GMT 2023 , Edited by admin on Sat Dec 16 19:58:10 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
504ZAM710C
Created by
admin on Sat Dec 16 19:58:10 GMT 2023 , Edited by admin on Sat Dec 16 19:58:10 GMT 2023
|
PRIMARY | |||
|
Fucosterol
Created by
admin on Sat Dec 16 19:58:10 GMT 2023 , Edited by admin on Sat Dec 16 19:58:10 GMT 2023
|
PRIMARY | |||
|
m5579
Created by
admin on Sat Dec 16 19:58:10 GMT 2023 , Edited by admin on Sat Dec 16 19:58:10 GMT 2023
|
PRIMARY | Merck Index | ||
|
5281328
Created by
admin on Sat Dec 16 19:58:10 GMT 2023 , Edited by admin on Sat Dec 16 19:58:10 GMT 2023
|
PRIMARY | |||
|
27865
Created by
admin on Sat Dec 16 19:58:10 GMT 2023 , Edited by admin on Sat Dec 16 19:58:10 GMT 2023
|
PRIMARY | |||
|
17605-67-3
Created by
admin on Sat Dec 16 19:58:10 GMT 2023 , Edited by admin on Sat Dec 16 19:58:10 GMT 2023
|
PRIMARY | |||
|
DTXSID701033229
Created by
admin on Sat Dec 16 19:58:10 GMT 2023 , Edited by admin on Sat Dec 16 19:58:10 GMT 2023
|
PRIMARY | |||
|
C015896
Created by
admin on Sat Dec 16 19:58:10 GMT 2023 , Edited by admin on Sat Dec 16 19:58:10 GMT 2023
|
PRIMARY |
SUBSTANCE RECORD